1982
DOI: 10.1111/j.1749-6632.1982.tb39485.x
|View full text |Cite
|
Sign up to set email alerts
|

The Use of Antidepressants With Methadone in Depressed Maintenance Patients *

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
14
0

Year Published

1988
1988
2017
2017

Publication Types

Select...
4
3

Relationship

0
7

Authors

Journals

citations
Cited by 39 publications
(14 citation statements)
references
References 8 publications
0
14
0
Order By: Relevance
“…Identification of factors associated with clinical retention may help in tailoring treatment approaches to reduce the risk of leaving treatment. For example, psychiatric comorbidity has predicted poor outcome in some studies and the provision of on-site psychotherapy or treatment for depression has improved treatment outcome (Woody et al, 1982; Woody et al, 1983; Nunes et al, 1991). Using evidence-based dosing regimens rather than set ceiling doses has also resulted in improved retention (Ball & Ross, 1991; Caplehorn & Bell, 1991).…”
Section: Discussionmentioning
confidence: 99%
“…Identification of factors associated with clinical retention may help in tailoring treatment approaches to reduce the risk of leaving treatment. For example, psychiatric comorbidity has predicted poor outcome in some studies and the provision of on-site psychotherapy or treatment for depression has improved treatment outcome (Woody et al, 1982; Woody et al, 1983; Nunes et al, 1991). Using evidence-based dosing regimens rather than set ceiling doses has also resulted in improved retention (Ball & Ross, 1991; Caplehorn & Bell, 1991).…”
Section: Discussionmentioning
confidence: 99%
“…None showed a clear effect on drug abuse. Methodological limitations 34 include small sample sizes, short trial lengths, low doses, and high placebo response rates, 29,30,32 perhaps because depressed subjects were selected with crosssectional symptom scales rather than clinical history and syndromal diagnosis. Depressive symptoms in substance abusers are often transient, [35][36][37] attributable to ORIGINAL ARTICLE a drug's toxic effects, drug withdrawal, or short-term life crises.…”
mentioning
confidence: 99%
“…Abrupt cessation can also cause a discontinuation syndrome. These data further show that TCAs, especially doxepin, also decreased symptoms of anxiety in this group (Kleber et al, 1983;Titievsky, Seco, Barranco, & Kyle, 1982;Woody, O'Brien, & Rickels, 1975;Woody, O'Brien, McLellan, Marcovici, & Evans, 1982). TCAs should be avoided in patients at risk of suicide (Nutt, 2005b).…”
Section: Pharmacological Treatmentsmentioning
confidence: 70%